Tissue Engineering

Global Soft Tissue Allografts Market

Fri, 03 Jun 2022 10:32:26 +0000

ResearchCubes Soft Tissue Allografts Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the critical & timely requirement of business information of medical devices business leaders. The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost. • What is the current Soft Tissue Allografts Treatment Devices Market size and future potential? • What is the geographical segmentation of the Soft Tissue Allografts Treatment Devices Market? • What are the emerging pipeline products available in the Soft Tissue Allografts Treatment Devices Market? • What are the various products currently under development/pipeline in the Soft Tissue Allograft...

$2,000.00

Tissue Engineered-Skin Substitutes (Wound Care Devices) - Global Market Analysis and Forecast Model

Fri, 21 Dec 2018 12:30:45 +0000

Summary

Tissue Engineered-Skin Substitutes (Wound Care Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Wound Care Devices therapeutic area.

Epidermal Wounds which show delayed healing process can lead to risks to a patient's health, including death and serious chronic wound formation. Skin substitutes have led to promising recovery practices for refractory wounds by providing cells, soluble mediators, and extracellular matrix materials needed to stimulate healing. Skin substitutes can be derived from human tissue, non-human tissue, a composite, or synthetic materials. The tissue engineered-skin substitutes market is segmented into cellular skin substitutes based on amniotic membrane, other cellular skin substitutes, acellular skin substitutes based on amniotic membrane, and other acellular skin substitutes.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparenc...

$7,500.00

Global Extremity Tissue Expanders Market Research Report 2018

Thu, 06 Dec 2018 15:57:36 +0000

Extremity Tissue Expanders Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Extremity Tissue Expanders basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) Basic Information; 2.) Asia Extremity Tissue Expanders Market; 3.) North American Extremity Tissue Expanders Market; 4.) European Extremity Tissue ...

$2,850.00

Global Regenerative Medicine Market Analysis & Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

Wed, 26 Apr 2017 12:43:51 +0000

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth $18.9 billion in 2016 and will grow to over $53.7 billion by 2021, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry will grow significantly at a CAGR of over x% and reach $x billion by 2021. Tissue engineering is forecast to grow at a CAGR of x% to 2021 and potentially reach $x billion. This report describes the evolution of such a huge market in 15 chapters supported by over 350 tables and figures in 680 pages. • An overview of regenerative medicine that includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies. • Global regenerative medicine market, global breakdown, application breakdown and leading market players • Detailed accou...

$4,900.00

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2016

Fri, 07 Apr 2017 13:51:23 +0000

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) Overview 6
Therapeutics Development 7
Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Products under Development by Stage of Development 7
Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Products under Development by Therapy Area 8
Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Products under Development by Indication 9
Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products...

$3,500.00

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2016

Fri, 07 Apr 2017 13:51:23 +0000

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) Overview 6
Therapeutics Development 7
Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) – Products under Development by Stage of Development 7
Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) – Products under Development by Therapy Area 8
Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) – Products under Development by Indication 9
Protei...

$3,500.00